By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoPhotonics 

4320 Forest Park Avenue
Suite 303
St. Louis  Missouri  63108  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Immunophotonics is a biotech company developing a proprietary drug for use in a therapeutic cancer vaccine (inCVAX). This novel immunotherapy begins with a two injection procedure into any one accessible tumor, intended to liberate and utilize the patient’s tumor antigens to generate a systemic antitumor immune response.

YEAR FOUNDED:

2009

LEADERSHIP:

Founder and CEO: Tomas Hode, PhD

COO Lu Alleruzzo, MBA

CDO (Chief Drug Dev. Officer): Joe Raker, PhD

FOLLOW IMMUNOPHOTONICS:



Key Statistics


Email:
Ownership: Private

Web Site: ImmunoPhotonics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->